1-43736288-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_006279.5(ST3GAL3):c.26A>G(p.Asn9Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000274 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N9H) has been classified as Uncertain significance.
Frequency
Consequence
NM_006279.5 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 15Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- intellectual disability, autosomal recessive 12Inheritance: AR Classification: STRONG Submitted by: G2P
- complex neurodevelopmental disorderInheritance: AR Classification: MODERATE Submitted by: ClinGen
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ST3GAL3 | ENST00000347631.8 | c.26A>G | p.Asn9Ser | missense_variant | Exon 2 of 12 | 5 | NM_006279.5 | ENSP00000317192.6 | ||
ENSG00000284989 | ENST00000645057.1 | n.*1348A>G | non_coding_transcript_exon_variant | Exon 16 of 26 | ENSP00000494063.1 | |||||
ENSG00000284989 | ENST00000645057.1 | n.*1348A>G | 3_prime_UTR_variant | Exon 16 of 26 | ENSP00000494063.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251484 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461882Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727244 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy Uncertain:1
This sequence change replaces asparagine with serine at codon 9 of the ST3GAL3 protein (p.Asn9Ser). The asparagine residue is moderately conserved and there is a small physicochemical difference between asparagine and serine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with ST3GAL3-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at